Actively Recruiting

Age: 18Years +
All Genders
NCT06624618

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit

Led by Maastricht University Medical Center · Updated on 2024-10-03

300

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

Sponsors

M

Maastricht University Medical Center

Lead Sponsor

H

Health Holland

Collaborating Sponsor

AI-Summary

What this Trial Is About

Rapid diagnosis of sepsis is crucial for treatment and survival. Currently, blood culture takes 48 hours-5 days to complete. After starting antimicrobial treatment blood culture results are not reliable. As a result, empirical broad spectrum antimicrobial therapy is mostly used. This implies possible antimicrobial over- or under treatment which is associated with increased antimicrobial resistance development. Early identification of the causative pathogen of sepsis will therefore have a major impact on the adequate treatment and reduction of high mortality rates. To date, there is not a single molecular diagnostic test available on the market to detect all putative causative bacterial pathogens of sepsis. In this study, the investigators will develop and validate a completely new molecular sepsis approach based on pathogen DNA detection, as an alternative to culture.

CONDITIONS

Official Title

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients are included when routine blood cultures are ordered for diagnosis of bloodstream infections.
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Maastricht University Medical Center

Maastricht, Limburg, Netherlands, 6229 HX

Actively Recruiting

Loading map...

Research Team

A

Anna Wijen, Msc.

CONTACT

P

Paul Savelkoul, Prof. Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Rapid Molecular Diagnosis of Sepsis in the Intensive Care Unit | DecenTrialz